
MDRPEDIA RECORDELITE · TIER IILIVING
Anil D’Cruz
Surgical Oncology (Head & Neck Oncology) · Apollo Hospitals · India
- h-index (OpenAlex)
- 110
- Papers on record · 5 on PubMed
- 5
- Stature
- Tier II
- Years in practice
- 35
- Last updated
- 17 Feb 26
EVIDENCE RECORD
What this record is built on
Compared with the register: Surgery · India · 35 years in practice · How it works
I · SCHOLARSHIP
- h-index
- 110 · 72nd pct
- Papers on record
- 5
- Citations received
- —
II · PRACTICE
- Licence
- Not yet checked
- Board certification
- —
- Registration ID
- —
- Institutions
- 2
III · LEARNING & TEACHING
- Trainees traced
- Not yet traced
- Mentors traced
- Not yet traced
- Invited talks
- —
IV · PEER STANDING
- Honours
- —
- Techniques pioneered
- —
- Ethics mark
- Not yet audited
Not on this record by design:Star ratingsAnonymous reviewsPaid placement
Record
Dr. Anil D'Cruz is a globally renowned surgical oncologist specializing in head and neck cancers. He served as the Director of Tata Memorial Hospital and held the prestigious position of President of the Union for International Cancer Control (UICC) from 2020 to 2022. Dr. D'Cruz led the landmark NEJM study on elective versus therapeutic neck dissection in oral cancer, which redefined global management standards. He is a recipient of the Padma Shri and the Dr. B. C. Roy Award.
IN PLAIN WORDS
- Practicing head & neck oncology specialist with 35+ years of experience
- Currently at Apollo Hospitals in India
What they treat and study
SPECIALTIES
CLINICAL KNOWLEDGE AND PROCEDURES
Institutions
QUESTIONS YOU MIGHT ASK AT A FIRST VISIT
- Is a procedure needed now, or can medicines and lifestyle changes help first?
- What are the risks and benefits of each option for someone like me?
- How many similar cases does your team see, and who will be involved in my care?
- Who do I contact if symptoms come back after treatment?
Landmark papers
- Papers on record
- 5
- Linked to PubMed
- 5
PUBLISHED IN N Engl J Med · J Clin Oncol · Cancer
- 2022Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.J Clin Oncoldoi 10.1200/JCO.21.00179PubMed ✓
- 2019A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer.Cancerdoi 10.1002/cncr.32179PubMed ✓
- 2019Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.J Clin Oncoldoi 10.1200/JCO.18.01921PubMed ✓
- 2018Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.J Clin Oncoldoi 10.1200/JCO.2017.74.9457PubMed ✓
- 2015Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.N Engl J Meddoi 10.1056/NEJMoa1506007PubMed ✓
Lineage
We haven't traced this physician's mentors and trainees yet. If you trained with them, you can add to the record.Contribute lineage
FOR THE DOCTOR
Are you Anil D’Cruz?
Claim this record to correct details, add your lineage and teaching, and embed your seal. Claims are checked against your registration before anything changes.

